Article

Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma

2022-05-20

Abstract excerpt

Background: COVID-19 convalescent plasma (CCP) contains neutralising anti-SARS-CoV-2 antibodies that may be useful as COVID-19 passive immunotherapy in patients at risk of developing severe disease. Such plasma from convalescent patients may also have additional immune-modulatory properties when transfused to COVID-19 patients.<br><br>Methods: CCP (n=766) was compared to non-convalescent control plasma (n=166) for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b3da60f4-2620-5fe0-97ea-a5b9b477d92e
DOI: 10.2139/ssrn.4115477

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent PlasmaDOI 10.2139/ssrn.4115477Read

Functional Antibodies in COVID-19 Convalescent PlasmaSemantic proximity Read

A Role for Nucleocapsid-Specific Antibody Function in COVID-19 Convalescent Plasma TherapySemantic proximity Read

Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.Semantic proximity Read

Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanismsSemantic proximity Read

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic reviewSemantic proximity Read

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceSemantic proximity Read

Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencingSemantic proximity Read

Evaluation of the Immunomodulatory Effects of Interleukin-10 on Peripheral Blood Immune Cells of COVID-19 Patients: Implication for COVID-19 TherapySemantic proximity Read

COVID-19 vaccination shifts neutrophils toward a mixed activated and regulatory phenotype in patients with severe disease.Semantic proximity Read

Clinical and Immunological Characteristics in COVID-19 Convalescent PatientsSemantic proximity Read

SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPYSemantic proximity Read

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal AntibodiesSemantic proximity Read